comparemela.com

Latest Breaking News On - Dhanuka laboratories - Page 1 : comparemela.com

Debt-free Orchid Pharma charts out growth plan

Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.

Cephalosporin Drugs Market Growth Strategies: Analyzing

Cephalosporin Drugs Market Growth Strategies: Analyzing
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Cephalosporin Drugs Market 2024 by Manufacturers, Regions,

Cephalosporin Drugs Market 2024 by Manufacturers, Regions,
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Orchid Chemicals & Pharma: Orchid all set to generate enough cash to fund expansion plans: Manish Dhanuka

“Three years back, when we started, we had a significant debt. But, today we are a debt-free company and we also have significant investment plans. We are well set to not just utilise our QIP cash that we are sitting on, but also generate enough cash to fund our expansion plans.”

Orchid Pharma Ltd rating updated by CARE Ratings Limited to CARE A-

Orchid Pharma Ltd rating updated by CARE Ratings Limited to CARE A-
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.